Epizyme logo
Epizyme EPZM

Quarterly report 2022-Q2
added 08-09-2022

report update icon

Epizyme Operating Cycle 2011-2026 | EPZM

Annual Operating Cycle Epizyme

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
47.2 834 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
834 47.2 441

Quarterly Operating Cycle Epizyme

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 28.4 65.5 - 151 78.9 244 296 376 582 191 54.5 41 39.7 131 189 153 153 - - 3.49 3.49 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
582 3.49 154

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Aclaris Therapeutics Aclaris Therapeutics
ACRS
6.01 $ 3.01 3.79 % $ 233 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
349 - -7.31 % $ 87 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
410 $ 11.86 2.24 % $ 781 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
195 $ 26.78 -0.81 % $ 1.3 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Certara Certara
CERT
88.6 $ 8.81 -0.56 % $ 1.41 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
325 $ 9.61 0.63 % $ 141 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
86.5 $ 27.16 2.76 % $ 1.75 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
136 $ 4.84 1.26 % $ 116 M franceFrance
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Axon Enterprise Axon Enterprise
AXON
116 $ 567.93 -0.73 % $ 43 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
360 $ 2.6 1.96 % $ 16.3 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
206 $ 91.93 -0.63 % $ 96.9 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
114 - -0.88 % $ 598 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
408 $ 11.29 -3.01 % $ 730 M usaUSA